Back to Search
AARON BILLIN, M.D.
M.D.
Emergency Medicine Physician
NPI: 1447296207Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
7737A(WY)
Emergency Medical Services (Emergency Medicine) Physician
Emergency Medicine — Emergency Medical Services
Code: 207PE0004X
7737A(WY)
Family Medicine Physician
Family Medicine
Code: 207Q00000X
7737A(WY)
Research & Publications (20)
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home.
PMID 18808307·Expert Opin Investig Drugs·2008
6-review
Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.
PMID 18800767·J Med Chem·2008
8-other
Discovery of a novel class of PPARdelta partial agonists.
PMID 18722772·Bioorg Med Chem Lett·2008
8-other
Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742.
PMID 18622687·Inflamm Res·2008
7-preclinical
PPARbeta/delta ligands as modulators of the inflammatory response.
PMID 18465655·Curr Opin Investig Drugs·2008
6-review
Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression.
PMID 18458340·Proc Natl Acad Sci U S A·2008
7-preclinical
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
PMID 18054822·Toxicology·2008
8-other
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.
PMID 17975020·Mol Endocrinol·2008
8-other
Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
PMID 17893232·Carcinogenesis·2008
7-preclinical
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
PMID 17693664·Carcinogenesis·2007
7-preclinical
The next generation of PPAR drugs: do we have the tools to find them?
PMID 17602866·Biochim Biophys Acta·2007
6-review
Co-crystal structure guided array synthesis of PPARgamma inverse agonists.
PMID 17533125·Bioorg Med Chem Lett·2007
8-other
PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism.
PMID 17404849·Dig Dis Sci·2007
7-preclinical
Expression profiling of peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray.
PMID 17333240·Histochem Cell Biol·2007
7-preclinical
A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
PMID 17290005·Mol Pharmacol·2007
7-preclinical
Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
PMID 17254750·Cell Signal·2007
7-preclinical
Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
PMID 17110604·Arterioscler Thromb Vasc Biol·2007
2-rct
The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.
PMID 16620032·Curr Top Microbiol Immunol·2006
6-review
Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
PMID 16618765·Cancer Res·2006
7-preclinical
PPARbeta/delta selectively induces differentiation and inhibits cell proliferation.
PMID 16021179·Cell Death Differ·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 777 AVENUE H
POWELL, WY 82435 - Phone
- (307) 754-7257
Quick Facts
- NPI
- 1447296207
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile